Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients by Gradman Alan H, Schmieder Roland E, Lins Robert L, Nussberger Juerg, Chiang Yanntong, Bedigian Martin P in Circulation (2005).

[PMID: 15723979] PubMed

Abstract

Discussed In Paper

Loading...

Dosing Information

No dosing information annotated.